BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 8635325)

  • 1. Ventilator-associated pneumonia due to Pseudomonas aeruginosa.
    Crouch Brewer S; Wunderink RG; Jones CB; Leeper KV
    Chest; 1996 Apr; 109(4):1019-29. PubMed ID: 8635325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.
    Kollef MH; Ward S
    Chest; 1998 Feb; 113(2):412-20. PubMed ID: 9498961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the duration of antibiotics on clinical events in patients with Pseudomonas aeruginosa ventilator-associated pneumonia: study protocol for a randomized controlled study.
    Bouglé A; Foucrier A; Dupont H; Montravers P; Ouattara A; Kalfon P; Squara P; Simon T; Amour J;
    Trials; 2017 Jan; 18(1):37. PubMed ID: 28114979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of clinical severity and outcome of ventilator-associated pneumonia. Comparison of simplified acute physiology score with systemic inflammatory mediators.
    Froon AH; Bonten MJ; Gaillard CA; Greve JW; Dentener MA; de Leeuw PW; Drent M; Stobberingh EE; Buurman WA
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1026-31. PubMed ID: 9769255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of combination therapy and early de-escalation on outcome of ventilator-associated pneumonia caused by Pseudomonas aeruginosa.
    Deconinck L; Meybeck A; Patoz P; Van Grunderbeeck N; Boussekey N; Chiche A; Delannoy PY; Georges H; Leroy O
    Infect Dis (Lond); 2017 May; 49(5):396-404. PubMed ID: 28092204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of APACHE II, SOFA and CPIS scores in predicting prognosis in patients with ventilator-associated pneumonia.
    Gursel G; Demirtas S
    Respiration; 2006; 73(4):503-8. PubMed ID: 16205047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis.
    Shorr AF; Sherner JH; Jackson WL; Kollef MH
    Crit Care Med; 2005 Jan; 33(1):46-53. PubMed ID: 15644647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia.
    Kollef MH; Morrow LE; Niederman MS; Leeper KV; Anzueto A; Benz-Scott L; Rodino FJ
    Chest; 2006 May; 129(5):1210-8. PubMed ID: 16685011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical significance of pneumonia in patients with respiratory specimens harbouring multidrug-resistant Pseudomonas aeruginosa: a 5-year retrospective study following 5667 patients in four general ICUs.
    Borgatta B; Gattarello S; Mazo CA; Imbiscuso AT; Larrosa MN; Lujàn M; Rello J
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2155-2163. PubMed ID: 28624864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of late-onset ventilator-associated pneumonia in determining patient mortality.
    Kollef MH; Silver P; Murphy DM; Trovillion E
    Chest; 1995 Dec; 108(6):1655-62. PubMed ID: 7497777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa.
    Kaminski C; Timsit JF; Dubois Y; Zahar JR; Garrouste-Orgeas M; Vesin A; Azoulay E; Feger C; Dumenil AS; Adrie C; Cohen Y; Allaouchiche B;
    Crit Care; 2011; 15(2):R112. PubMed ID: 21481266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: an observational, multicenter study comparing monotherapy with combination antibiotic therapy.
    Garnacho-Montero J; Sa-Borges M; Sole-Violan J; Barcenilla F; Escoresca-Ortega A; Ochoa M; Cayuela A; Rello J
    Crit Care Med; 2007 Aug; 35(8):1888-95. PubMed ID: 17581492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling.
    George DL; Falk PS; Wunderink RG; Leeper KV; Meduri GU; Steere EL; Corbett CE; Mayhall CG
    Am J Respir Crit Care Med; 1998 Dec; 158(6):1839-47. PubMed ID: 9847276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of the clinical features and outcome of ventilator-associated Pseudomonas aeruginosa-related pneumonia in an intensive care unit].
    Baĭgozina EA; Sovalkin VI; Lukach VN
    Anesteziol Reanimatol; 2009; (2):62-4. PubMed ID: 19514444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU.
    Mehta S; McGeer A; Low DE; Hallett D; Bowman DJ; Grossman SL; Stewart TE
    Chest; 2006 Dec; 130(6):1679-86. PubMed ID: 17166982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is ventilator-associated pneumonia an independent risk factor for death?
    Bregeon F; Ciais V; Carret V; Gregoire R; Saux P; Gainnier M; Thirion X; Drancourt M; Auffray JP; Papazian L
    Anesthesiology; 2001 Apr; 94(4):554-60. PubMed ID: 11379672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial.
    Chastre J; Wolff M; Fagon JY; Chevret S; Thomas F; Wermert D; Clementi E; Gonzalez J; Jusserand D; Asfar P; Perrin D; Fieux F; Aubas S;
    JAMA; 2003 Nov; 290(19):2588-98. PubMed ID: 14625336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.